Stay informed with the latest updates for the inheritable blood disorders community.

Advocacy & Legislative
Tell Congress to Vote No on AHCA
Tell Congress to Vote No on AHCA
Advocacy & Legislative
NHF Letter to the House of Representatives
NHF Letter to the House of Representatives
Medical
340B Program Module Available through Partners in Bleeding Disorders Education
340B Program Module Available through Partners in Bleeding Disorders…
Advocacy & Legislative
Washington Days Brings Big Crowd to Capitol Hill
Washington Days Brings Big Crowd to Capitol Hill
Industry
Shire’s Phase 3 Trial Will Evaluate PK-Guided Prophylaxis with ADYNOVATE®
Shire’s Phase 3 Trial Will Evaluate PK-Guided Prophylaxis with ADYNOVATE®
Medical
Dental Management Module Available through Partners in Bleeding Disorders Education
Dental Management Module Available through Partners in Bleeding…
Advocacy & Legislative
This Could Be the Biggest Washington Days in Our History
This Could Be the Biggest Washington Days in Our History
NBDF & Community
Take the Red Tie Challenge!
Take the Red Tie Challenge!
NBDF & Community
My Life, Our Future Opens World’s Largest Genetic Hemophilia Repository to Scientists
My Life, Our Future Opens World’s Largest Genetic Hemophilia…
Industry
Spark Therapeutics Announces Initiation of Phase 1/2 Trial
Spark Therapeutics Announces Initiation of Phase 1/2 Trial
Industry
Important Statement on HAVEN 1 Clinical Trial
Important Statement on HAVEN 1 Clinical Trial
Advocacy & Legislative
Washington Days Webinar
Washington Days Webinar
Medical
Partners in Bleeding Disorders Education Relaunches Online Ethics Activity
Partners in Bleeding Disorders Education Relaunches Online Ethics Activity…
Medical
Request for Proposals: WFH World Bleeding Disorders Registry
Request for Proposals: WFH World Bleeding Disorders Registry
Industry
FDA Accepts New Drug Application for AbbiVie’s HCV Combination Therapy